Answers - Finance

The IRS, or Internal Revenue Service, is the tax collection and enforcement agency of th

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e Treasury Department of the USA. It goes without saying that there are harsh penalties

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

nd fines for tax evaders, though at times, even honest taxpayers find themselves at the

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

eceiving end of the IRS. This may be because they have either underpaid or overpaid thei

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

taxes.

In most cases, people are willing to pay taxes. The problem arises when they ar

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e unable to interpret the tax laws correctly and as a result have to face the wrath of t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

e revenue department. The problem is compounded by the fact that in most cases the attit

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

de of the IRS is so harsh that people have to consult tax law firms to get the issues re

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

olved.

Millions of US citizens have at some time or the other received notices from the

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

IRS. These notices can be due to nonpayment or underpayment of taxes. Of course, there

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

re cases of overpayment also, but the IRS is not as zealous in refunding taxes as it is

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

n collecting them. So, if you are unfortunate enough to pay more than you were required,

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rest assured you will not get a refund without some struggle.

You need to be conversant

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

with the tax laws in order to calculate tax dues yourself. Otherwise, you may underpay

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

our taxes, and this would invite strict penalties. The other option is to hire the servi

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

es of a well-established law firm, which for a fee would calculate your dues. In case of

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

some financial liabilities where you are not in a position to pay the full amount of you

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

r dues, the tax law firm can work out structured installments in agreement with the IRS

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

nd, in this way, bail you out of a difficult situation.

You also have the option of con

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ulting the RO (revenue officer). He can go through your payment records and help you out

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/119186/answers-IRS-Tax-Problem-Help.html">IRS Tax Problem Help</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/119186/answers-IRS-Tax-Problem-Help.html]IRS Tax Problem Help[/url]

Many not-for-profits provide valuable programs within the communities that they serve. Often these services are provided to individuals and families who may not be able to afford these needed services. Therefore, in order for the not-for-profit to raise the needed financial resources they have to engage in an aggressive fundraising program.

Web search engines work by storing information about a large number of web pages, which they retrieve from the WWW itself.

While applying for car loans with bad credit, how good a deal you get depends on your credit report.

Tags

Links

Answers - IRS Tax Problem Help

Related Articles: